Magnolol protects neurons against ischemia injury via the downregulation of p38/MAPK, CHOP and nitrotyrosine

https://doi.org/10.1016/j.taap.2014.07.005Get rights and content

Highlights

  • Magnolol attenuates brain damage in ischemic rats.

  • Effects of magnolol on stroke animals in ROS and acute inflammation cytokines.

  • Oxidants and Akt/NF-κB signaling are involved in the neuroprotection of magnolol.

Abstract

Magnolol is isolated from the herb Magnolia officinalis, which has been demonstrated to exert pharmacological effects. Our aim was to investigate whether magnolol is able to act as an anti-inflammatory agent that brings about neuroprotection using a global ischemic stroke model and to determine the mechanisms involved. Rats were treated with and without magnolol after ischemia reperfusion brain injury by occlusion of the two common carotid arteries. The inflammatory cytokine production in serum and the volume of infarction in the brain were measured. The proteins present in the brains obtained from the stroke animal model (SAM) and control animal groups with and without magnolol treatment were compared. Magnolol reduces the total infarcted volume by 15% and 30% at dosages of 10 and 30 mg/kg, respectively, compared to the untreated SAM group. The levels of acute inflammatory cytokines, including interleukin-1 beta, tumor necrosis factor alpha, and interleukin-6 were attenuated by magnolol. Magnolol was also able to suppress the production of nitrotyrosine, 4-hydroxy-2-nonenal (4-HNE), inducible NO synthase (iNOS), various phosphorylated p38 mitogen-activated protein kinases and various C/EBP homologues. Furthermore, this modulation of ischemia injury factors in the SAM model group treated with magnolol seems to result from a suppression of reactive oxygen species production and the upregulation of p-Akt and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB). These findings confirm the anti-oxidative properties of magnolol, including the inhibition of ischemic injury to neurons; this protective effect seems to involve changes in the in vivo activity of Akt, GSK3β and NF-κB.

Graphical abstract

Schematic presentation of the signaling pathways involved in magnolol inhibited transient global ischemia brain apoptosis and inflammation in rats. The effect of magnolol on the scavenger of ROS, which inhibits p38 MAPK and CHOP protein inactivation. These results suggest that another role for the iNOS/Akt pathway may be involved in neuronal survival or plasticity by magnolol after ischemic injury.

  1. Download : Download high-res image (25KB)
  2. Download : Download full-size image

Introduction

Magnolol, a major active agent isolated from the herb Magnolia officinalis (Chinese herbal name: Hou Pu) is a poly-phenolic compound that exerts its biological properties through a variety of mechanisms (Alonso-Castro et al., 2011, Domínguez et al., 2010). Magnolol has been extensively documented and possesses a range of therapeutic properties such as anxiolytic activity (Kuribara et al., 2000), analgesic activity (Lin et al., 2009), antidepressant activity (Qiang et al., 2009), antimicrobial activity (Kim et al., 2010), antispasmodic activity (Ko et al., 2003), anti-tumorigenic activity (Chen et al., 2009) and an anti-Alzheimer's therapeutic effect (Hoi et al., 2010). Importantly, a recent study has indicated that oral magnolol seems to prevent age-related memory and learning deficits found in senescence-accelerated mice and does this by preserving cholinergic neurons (Lin et al., 2006, Matsui et al., 2009a, Matsui et al., 2009b). However, the mechanism by which the magnolol initiates neuroprotection against ischemic injury to the brain remains poorly understood.

Stroke is the fourth-leading cause of death and the primary cause of long-term disability worldwide (Iadecola and Anrather, 2011). It involves a distinct sequence of events that are not yet fully elucidated. Ischemic insult induces excessive generation of free radicals (reactive oxygen species (ROS) and reactive nitrogen species (RNS)), which then cause endoplasmic reticulum stress, which is signaled by both increased circulating levels of proinflammatory cytokines (TNF, IL-6) and the induction of macrophage infiltration that has been linked to apoptosis by the inducible NOS (iNOS) activation; these events then induce apoptotic cell death in neurons (Towfighi and Saver, 2011). Further ischemic stroke events also occur and these include neurotoxicity mediated by the production of free radicals and a subsequent induction of the p38 MAPK/CHOP pathway that is involved in ER stress-induced apoptosis of neurons; these findings are supported by the fact that ischemic injury is reduced following the induction of endogenous antioxidant pathways and the presence of scavengers targeting nitric oxide (Gotoh and Mori, 2006). As a result of the above findings, a fundamental role as potential neuroprotective agents is recognized for free radical scavengers. This is because ischemic injury is caused by a series of events that involve energy depletion and cell death and these are mediated by various intermediate factors including excess extracellular excitatory free radical formation and the presence of inflammation (Kohno et al., 1997). After arterial occlusion, necrotic cell death occurs predominantly in the ischemic core (Iadecola and Anrather, 2011). Reduced blood flow resulting from arterial occlusion or hypotension leads to tissue hypoxia and hypoglycemia, which then cause protein misfolding and endoplasmic reticulum stress. Ischemia-reperfusion injury of the brain then induces oxidative stress, which leads to production of nitric oxide (NO), a mediator of protein nitrosylation, and other reactive oxygen species (ROS); these alter cellular redox-dependent reactions and have an effect on protein misfolding (Zhu et al., 2003). Despite efforts to develop novel drugs to rescue neurons from delayed neuronal death in the penumbral region of the ischemic core, few currently available drugs are able to effectively treat stroke patients. In the present study we shall explore the biological agent of magnolol and its effect on ischemia reperfusion injury.

Reactive oxygen species derived from ischemia-reperfusion have been shown to be associated with the phosphatidylinositol 3-kinase (PI3K) and Akt signaling pathway that leads to neuronal survival or death (Noshita et al., 2001). PI3K/Akt is a major cell survival pathway that has been extensively studied. The PI3K/Akt pathway promotes cellular survival and cell cycling by phosphorylating and inhibiting death-inducing proteins; this includes phosphorylation of glycogen synthase kinase-3 beta (GSK-3β), and various activation-associated nuclear translocation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB)-dependent prosurvival genes (Camandola and Mattson, 2007). Considering the key role of PI3K/Akt and NF-κB in cell survival when studied using a stroke model of ischemia reperfusion brain injury, in the present study we sought to determine whether magnolol is able to effectively improve the neuroprotective effects of PI3K/Akt and NF-κB.

In our current study, a cerebral global ischemic stroke model of temporary ischemia followed by reperfusion onset was used to assess whether magnolol has a neuroprotective effect. We were able to demonstrate that magnolol, a known antioxidant, is able to reduce the oxidative endoplasmic reticulum stress that is generated by global cerebral ischemic injury, thus promoting neuronal cells survival; this involved the p38 mitogen-activated protein kinases (MAPKs), C/EBP homologous protein (CHOP) and the Akt/ NF-κB signal pathway.

Section snippets

Surgery to induce ischemia reperfusion brain injury and drug administration

Adult male Sprague–Dawley rats weighing around 280 ± 20 g were kept individually in a 12-hour light/dark cycle cage and had free access to water and food. Animal care and the general protocols for animal use were approved by the Institutional Animal Care and Use Committee of National Yang-Ming University. All efforts were made to minimize the number of animals used and their suffering. These rats were operated on according to the modified global cerebral ischemia's model, which involves occlusion

Magnolol attenuates brain damage in ischemic rats

A recent investigation has shown that magnolol and its structural analog honokiol are able to promptly cross the blood brain barrier, which then allows them to exert neuroprotective effects on the central nervous systems of ischemic stroke subjects (Lee et al., 2012, Lin et al., 2012). Based on these studies, we tested whether magnolol provides tangible therapeutic benefits by quenching brain impairment in a rat model that resembles ischemic stroke. As shown in Fig. 1A, injection of magnolol

Discussion

This study clearly demonstrates how magnolol suppresses oxidative stress and p38/MAPK and CHOP protein expression after ischemic injury, thus conferring neuroprotection. Magnolol also seems to have another role in that it affects iNOS expression and the Akt/NF-kB pathways, which are involved in neuronal survival/plasticity after ischemia reperfusion injury.

Ischemic damage occurs when the continuity of oxygen and glucose delivery via blood flow in the brain is interrupted (Moskowitz et al., 2010

Conflict of interest

The authors state no conflict of interest.

Acknowledgments

We are grateful to Li-Fu Chen for valuable contributions to the study design and later discussion. This study was supported by grants CGH-MR-9913, RD2011008, CZRPG880253, CMRPF6A0073 and CMRPF6C0032 from Cathay General Hospital, National Yang-Ming University Hospital, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung Memorial Hospital, and Chang Gung University of Science and Technology, Chia-Yi Campus, Taiwan, respectively, and from the National Science Council, Taiwan (

References (45)

  • K. Yamanaka et al.

    Cellular expression of inducible nitric oxide synthase following rat cortical incision and its suppression by hydroxyl radical scavenger, 1,2-bis(nicotinamido)propane

    Neurosci. Res.

    (1998)
  • P. Blume-Jensen et al.

    The Kit receptor promotes cell survival via activation of PI 3-kinase and subsequent Akt-mediated phosphorylation of Bad on Ser136

    Curr. Biol.

    (1998)
  • S. Camandola et al.

    NF-kappa B as a therapeutic target in neurodegenerative diseases

    Expert Opin. Ther. Targets

    (2007)
  • L.C. Chen et al.

    Magnolol inhibits human glioblastoma cell proliferation through upregulation of p21/Cip1

    J. Agric. Food Chem.

    (2009)
  • D.Y. Chuang et al.

    Magnolia polyphenols attenuate oxidative and inflammatory responses in neurons and microglial cells

    J. Neuroinflammation

    (2013)
  • D.A. Cross et al.

    Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

    Nature

    (1995)
  • F. Domínguez et al.

    Honokiol and magnolol production by in vitro micropropagated plants of Magnolia dealbata, an endangered endemic Mexican species

    Nat. Prod. Commun.

    (2010)
  • H.K. Eltzschig et al.

    Hypoxia and inflammation

    N. Engl. J. Med.

    (2011)
  • F. Engin et al.

    Restoring endoplasmic reticulum function by chemical chaperones: an emerging therapeutic approach for metabolic diseases

    Diabetes Obes. Metab.

    (2010)
  • T. Gotoh et al.

    Nitric oxide and endoplasmic reticulum stress

    Arterioscler. Thromb. Vasc. Biol.

    (2006)
  • M. Hetman et al.

    Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal

    J. Neurosci.

    (2000)
  • C.P. Hoi et al.

    Neuroprotective effect of honokiol and magnolol, compounds from Magnolia officinalis, on beta-amyloid-induced toxicity in PC12 cells

    Phytother. Res.

    (2010)
  • Cited by (45)

    • The potential role of herbal medicine and nutraceutical in neuroinflammatory disorders: A mechanistic insight via multisignaling cascades

      2023, Treatments, Nutraceuticals, Supplements, and Herbal Medicine in Neurological Disorders
    • Magnolol limits NFκB-dependent inflammation by targeting PPARγ relieving retinal ischemia/reperfusion injury

      2022, International Immunopharmacology
      Citation Excerpt :

      Effectively neuroprotective medicines are badly needed. Previous studies revealed MAG has neuroprotective and anti-inflammatory effects in neurons [11,23]. Fig. 1A is the chemical structure of MAG.

    View all citing articles on Scopus
    View full text